113984-64-8

Basic information

• Product Name: Benzaldehyde, 3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-fluoro-
• CAS NO: 113984-64-8
• Molecular Formula: C19H33FO3Si2
• Molecular Weight: 384.639
• Mol File: 113984-64-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-fluoro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-fluoro-(113984-64-8)
• EPA Substance Registry System: Benzaldehyde, 3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-fluoro-(113984-64-8)

Safety Data

• Hazardous Substances Data: 113984-64-8(Hazardous Substances Data)

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 371-41-5 4-Fluorophenol 
• 113984-75-1 3,5-bis-(tert-butyl-dimethyl-silanyloxy)-2-fluorobenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 113984-74-0 4-(tert-butyldimethylsilyloxy)-1-fluoro-2-hydroxybenzene 
• 113984-68-2 4-<(dimethyl-tert-butylsilyl)oxy>fluorobenzene 

Downstream Products

• 113984-72-8 3,5-Bis-benzyloxy-2-fluoro-benzaldehyde 
• 277324-22-8 (4-cyano-phenylamino)-(3,5-diethoxy-2-fluoro-phenyl)-acetic acid ethyl ester 
• 132362-07-3 (5,7-Bis-benzyloxy-4-fluoro-1H-indol-3-ylmethyl)-trimethyl-ammonium; iodide 
• 132303-37-8 5,7-Bis-benzyloxy-4-fluoro-1H-indole-2-carboxylic acid methyl ester 
• 132303-50-5 (5,7-Bis-benzyloxy-4-fluoro-1H-indol-3-yl)-acetonitrile 
• 132303-40-3 5,7-Bis-benzyloxy-4-fluoro-1H-indole-2-carbaldehyde 
• 132303-53-8 2-(5,7-Bis-benzyloxy-4-fluoro-1H-indol-3-yl)-ethylamine 
• 132303-46-9 (5,7-Bis-benzyloxy-4-fluoro-1H-indol-3-ylmethyl)-dimethyl-amine 
• 132303-43-6 5,7-Bis-benzyloxy-4-fluoro-1H-indole 
• 113984-71-7 2-fluoro-3,5-dimethoxy-benzaldehyde 
• 120951-87-3 2-Fluoro-3,5-dihydroxy-benzaldehyde 
• 277324-21-7 3,5-diethoxy-2-fluorobenzaldehyde 

Relevant articles and documents

Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity

The discovery of a highly potent and selective tissue factor/factor VIIa inhibitor is described. Upon oral administration of its double prodrug in the guinea pig, a dose-dependent antithrombotic effect is observed in an established model of arterial throm

tert-BUTYLDIMETHYLSILYL ETHERS OF PHENOLS: THEIR ONE-STEP CONVERSION TO BENZYL OR METHYL ETHERS AND UTILITY IN REGIOSELECTIVE ortho LITHIATION

A new method for the one-step conversion of tert-butyldimethylsilyl ethers of phenols to benzyl or methyl ethers and the blocking effect of the tert-butyldimethylsilyloxy group in regioselective ortho lithiation are described.